In reference to hereditary hemorrhagic telangiectasia/avastin.
Bachmann-Harildstad
Gregor
G
D000281:Administration, Intranasal; D020533:Angiogenesis Inhibitors / Q000008:administration & dosage*; D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab; D004844:Epistaxis / Q000188:drug therapy* / Q000209:etiology; D006801:Humans; D013683:Telangiectasia, Hereditary Hemorrhagic / Q000150:complications*; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors*
D020533:Angiogenesis Inhibitors; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D042461:Vascular Endothelial Growth Factor A; D000068258:Bevacizumab